• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药学驱动的床边出院药物递送计划对30天再入院率的影响。

Effect of Pharmacy-Driven Bedside Discharge Medication Delivery Program on Day 30 Hospital Readmission.

作者信息

Lam Simon W, Sokn Erick

机构信息

Pharmacoeconomics and Outcomes Research, Department of Pharmacy, 2569Cleveland Clinic, Cleveland, OH, USA.

Transitions of Care, Department of Pharmacy, 2569Cleveland Clinic, Cleveland, OH, USA.

出版信息

J Pharm Pract. 2020 Oct;33(5):628-632. doi: 10.1177/0897190019825961. Epub 2019 Feb 6.

DOI:10.1177/0897190019825961
PMID:30727808
Abstract

BACKGROUND

Previous studies demonstrated that transitions of care bundles, which include bedside discharge medication delivery (BDMD), may be helpful in decreasing hospital readmissions.

OBJECTIVE

To evaluate the effects of BDMD alone on day 30 readmission rates.

METHODS

Retrospective, cohort study comparing those who received pharmacy-driven BDMD to usual discharge. Primary outcome was day 30 readmission rates. Multivariable logistic regression was used to account for baseline differences between groups.

RESULTS

A total of 30916 patients met inclusion and exclusion criteria. Of those, 2253 (7%) received BDMD and 28663 (93%) received usual care. Significant differences in age, distance from hospital, race, marital status, insurance type, previous hospitalizations, admission source, baseline comorbidities, and medication counts were observed between groups. Patients who received BDMD were less likely to have day 30 readmissions (10.6% vs 12.8%, = .002). However, after adjusting for baseline characteristics, BDMD was not an independent predictor of day 30 readmission (adjusted odds ratio = 0.91, 95% confidence interval = 0.79-1.04, = .17). BDMD was associated with decreased day 14 readmissions in an unadjusted analysis.

CONCLUSIONS

BDMD was not independently associated with a reduction in day 30 readmissions. Future studies should focus on targeting patients who are most likely to benefit from this service.

摘要

背景

先前的研究表明,包括床边出院药物配送(BDMD)在内的护理束过渡可能有助于降低医院再入院率。

目的

评估单独使用BDMD对30天再入院率的影响。

方法

回顾性队列研究,比较接受药学驱动的BDMD与常规出院的患者。主要结局是30天再入院率。采用多变量逻辑回归分析来考虑组间的基线差异。

结果

共有30916例患者符合纳入和排除标准。其中,2253例(7%)接受了BDMD,28663例(93%)接受了常规护理。两组在年龄、离医院距离、种族、婚姻状况、保险类型、既往住院史、入院来源、基线合并症和用药数量方面存在显著差异。接受BDMD的患者30天再入院的可能性较小(10.6%对12.8%,P = .002)。然而,在调整基线特征后,BDMD不是30天再入院的独立预测因素(调整后的比值比 = 0.91,95%置信区间 = 0.79 - 1.04,P = .17)。在未调整的分析中,BDMD与14天再入院率降低相关。

结论

BDMD与30天再入院率的降低没有独立关联。未来的研究应聚焦于确定最可能从这项服务中获益的患者。

相似文献

1
Effect of Pharmacy-Driven Bedside Discharge Medication Delivery Program on Day 30 Hospital Readmission.药学驱动的床边出院药物递送计划对30天再入院率的影响。
J Pharm Pract. 2020 Oct;33(5):628-632. doi: 10.1177/0897190019825961. Epub 2019 Feb 6.
2
Impact of a pharmacist collaborative drug therapy management protocol on utilization of a discharge prescription program and hospital readmissions.药师协作药物治疗管理方案对出院带药方案使用和医院再入院的影响。
Am J Health Syst Pharm. 2023 Aug 4;80(16):1056-1062. doi: 10.1093/ajhp/zxad079.
3
Impact of medication bedside delivery program on hospital readmission rates.药物床边送达方案对医院再入院率的影响。
J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):95-100.e1. doi: 10.1016/j.japh.2020.09.023. Epub 2020 Nov 13.
4
Assessing the impact of adding pharmacist management services to an existing discharge planning program on 30-day readmissions.评估在现有出院计划项目中增加药剂师管理服务对 30 天再入院率的影响。
J Am Pharm Assoc (2003). 2022 May-Jun;62(3):734-739. doi: 10.1016/j.japh.2021.12.005. Epub 2021 Dec 18.
5
Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center.一项由药房推动的护理过渡计划对一家全国性综合癌症中心出院后医疗保健利用情况的影响。
Am J Health Syst Pharm. 2018 Sep 15;75(18):1386-1393. doi: 10.2146/ajhp170747. Epub 2018 Jul 31.
6
Effects of a pharmacist-driven intervention program on hospital readmissions.药剂师主导的干预项目对医院再入院情况的影响。
Am J Health Syst Pharm. 2018 May 1;75(9):e221-e230. doi: 10.2146/ajhp170287.
7
Impact of a community pharmacy transitions-of-care program on 30-day readmission.社区药房过渡期计划对 30 天再入院的影响。
J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):202-209. doi: 10.1016/j.japh.2018.10.011. Epub 2018 Dec 11.
8
Impact of discharge medication bedside delivery service on hospital reutilization.出院带药床边交付服务对医院再利用的影响。
Am J Health Syst Pharm. 2019 Nov 13;76(23):1951-1957. doi: 10.1093/ajhp/zxz197.
9
Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index.运用再入院预测指数评价多学科方法对减少内科再入院率的效果。
Am J Health Syst Pharm. 2020 Jun 4;77(12):950-957. doi: 10.1093/ajhp/zxaa078.
10
Impact of an Integrated Pharmacy Transitions of Care Pilot Program in an Urban Hospital.城市医院综合药学护理过渡试点项目的影响
J Pharm Pract. 2016 Oct;29(5):490-4. doi: 10.1177/0897190014568674. Epub 2015 Mar 5.

引用本文的文献

1
Pharmacist-led interventions at hospital discharge: a scoping review of studies demonstrating reduced readmission rates.药师主导的出院干预措施:对显示再入院率降低的研究的范围综述
Int J Clin Pharm. 2025 Feb;47(1):15-30. doi: 10.1007/s11096-024-01821-y. Epub 2024 Dec 9.
2
Impact of a Meds to Beds Program on Re-presentation Rates in Medical and Surgical Patients at a Community Hospital.药物到病床项目对社区医院内科和外科患者再就诊率的影响。
HCA Healthc J Med. 2021 Jun 28;2(3):215-222. doi: 10.36518/2689-0216.1174. eCollection 2021.
3
Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission.
出院前床边给药评估:对 30 天再入院的影响。
J Manag Care Spec Pharm. 2020 Mar;26(3):296-304. doi: 10.18553/jmcp.2020.26.3.296.
4
Impact of a Pharmacy-Led Transition of Care Service on Post-Discharge Medication Adherence.由药房主导的护理转接服务对出院后药物依从性的影响。
Pharmacy (Basel). 2019 Aug 31;7(3):128. doi: 10.3390/pharmacy7030128.